Historical Appendix K Codes for Casefinding 2012 ICD-9-CM

Historic Appendix K Codes for Casefinding Jan 1 through Dec 31, 2012

Screening List of OF ICD-9-CM Codes for Casefinding

Certain ICD-9-CM* codes used by medical records departments for discharge diagnoses identify cases of malignant neoplasms that are reportable to the California Cancer Registry. Case finding procedures must include the review of medical records coded with the following numbers. Newly reportable diseases are followed by the ICD-O-3 morphology and behavior code in parentheses.

Note: Casefinding codes for borderline ovarian tumors (235.0-236.6) are included in the Supplementary List #2.

Historical ICD-9-CM Codes:

The following information is taken directly from the SEER web site: http://seer.cancer.gov/tools/casefinding/case2012long.html.

Fiscal Year 2012 ICD-9-CM Casefinding List: Expanded Version

Some ranges are expressed with only 1 decimal place (e.g. 237.0-237.9) while some codes within that range may have two decimal places (e.g. 237.71 and 237.72). All codes in the range are included.

These tables are also available in a printable version (PDF).

2012 Comprehensive ICD-9-CM Casefinding Code List for Reportable Tumors (with equivalent ICD-10-CM codes)
Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List

ICD-9-CM Code*	ICD-10-CM Code**	Explanation of ICD-9-CM Code
140._ – 172._ 174._ – 209.36 209.7_	C00._ – C96 ._	Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies
173.00 173.09	C44.00 C44.09	Unspecified and other specified malignant neoplasm of skin of lip
173.10 173.19	C44.101 C44.191	Unspecified and other specified malignant neoplasm of eyelid, including canthus
173.20 173.29	C44.201 C44.291	Unspecified and other specified malignant neoplasm of ear and external auricular canal
173.30 173.39	C44.30 C44.39	Unspecified and other specified malignant neoplasm of skin of other and unspecified parts of face
173.40 173.49	C44.40 C44.49	Unspecified and other specified malignant neoplasm of scalp and skin of neck
173.50 173.59	C44.50_ C44.59_	Unspecified and other specified malignant neoplasm of skin of trunk, except scrotum
173.60 173.69	C44.601 C44.691	Unspecified and other specified malignant neoplasm of skin of upper limb, including shoulder
173.70 173.79	C44.701 C44.791	Unspecified and other specified malignant neoplasm of skin of lower limb, including hip
173.80 173.89	C44.80 C44.89	Unspecified and other specified malignant neoplasm of other specified sites of skin
173.90 173.99	C44.90 C44.99	Unspecified and other specified malignant neoplasm of skin, site unspecified
225.0 – 225.9	D32._ – D33._	Benign neoplasm of brain and spinal cord neoplasm
227.3 227.4	D35.2 D35.3	Benign neoplasm of pituitary gland, craniopharyngeal duct (pouch) and pineal gland
228.02	D18.02	Hemangioma; of intracranial structures
228.1	D18.1	Lymphangioma, any site Note: Includes only lymphangioma of the brain, other parts of nervous system and endocrine gland
230.0 – 234.9	D00._ – D09._	Carcinoma in situ
237.0 – 237.1	D44.3 – D44.5	Neoplasm of uncertain behavior of endocrine glands and nervous system: pituitary gland, carniopharyngeal duct and pineal gland
237.5 237.6 237.9	D42._ D43.0 D43.2 – D43.4 D43.7 – D43.9	Neoplasm of uncertain behavior of endocrine glands and nervous system: brain and spinal cord, meninges, endocrine glands and other and unspecified parts of nervous system
238.4	D45	Polycythemia vera
238.6	D47.Z9	Plasma cells
238.7_	D46._ D47._	Other lymphatic and hematopoietic diseases
239.6 239.7	D49.6	Neoplasms of unspecified nature, brain, endocrine glands and other parts of nervous system
273.3	C88.0	Macroglobulinemia (Waldenstrom’s macroglobulinemia)
277.89	C96.5 C96.6	Other specified disorders of metabolism Reportable includes terms: Hand-Schuller-Christian disease; histiocytosis (acute)(chronic); histiocytosis X (chronic)
288.4	D76.1 – D76.3	Hemophagocytic syndrome (histiocytic syndromes
289.6	D45	Familial polycythemia (synonym for polycythemia vera)

The following codes are not reportable per se, but they should alert registrars to look for the first malignant neoplasm associated with these codes.

2012 Supplementary List #1 ICD-9-CM Codes That Should be Followed by or Associated with a Neoplasm Code (with Equivalent ICD-10-CM Codes)

ICD-9-CM Code*	ICD-10-CM Code**	Explanation of ICD-9-CM Code
258.0_	E31.22 E31.23	Polyglandular activity in multiple endocrine adenomatosis [MEN] Note: Use additional codes to identify any malignancies and other conditions associated with the syndromes
284.2	D61.82	Myelophthisis Note: Code first the underlying disorder, such as: malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
285.22	D63.0	Anemia in neoplastic disease Note: Assign also a code for the neoplasm causing the anemia
289.83	D75.81	Myelofibrosis (9961/3) Note: Code first the underlying disorder, such as: malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
331.7	G94	Cerebral degeneration in diseases classified elsehwere Note: code first underlying disease, such as neoplastic disease (140.-239.9)
336.3	G99.2	Myelopathy in other diseases classified elsewhere Note: Code first underlying disease as: myelopathy in neoplastic disease (140.0-239.9)
357.3	G13.0 G13.1	Polyneuropathy in malignant disease Note: Code first underlying disease (140.0-208.9)
358.1	G73.3	Myasthenic syndromes in other diseases classified elsewhere Note: code first underlying disease, such as neoplasm (C00-D49)
358.31	G73.1	Eaton-Lambert syndrome in neoplastic disease (Effective 10/1/2011)
511.81	J91.0	Malignant pleural effusion Note: Code first malignant neoplasm, if known
512.82	J93.12	Secondary spontaneous pneumothorax Note: Code first underlying condition such as: cancer metastatic to lung (197.0) or primary lung cancer (162.3-162.9)
731.1_	M90.6_	Osteitis deformans in diseases classified elsewhere Note: Code first underlying malignant neoplasm of bone (170.0-170.9)
731.3	M89.70_	Major osseous defect Note: Code first underlying malignancy, if known, such as: Malignant neoplasm of bone (170.0-170.9)
789.51	R18.0	Malignant ascites Note: Code first malignancy
V07.5_	Z79.81_	Prophylactic use of agents affecting estrogen receptors and estrogen levels Note: code first, if applicable: malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
V58.42	Z48.3	Aftercare following surgery for neoplasm Note: Conditions classifiable to 140-239

Note: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases.

2012 Supplementary List #2 ICD-9-CM Code List to Screen for Cancer Registry Cases Not Identified by Other Codes (with equivalent ICD-10-CM codes)

ICD-9-CM Code*	ICD-10-CM Code**	Explanation of ICD-9-CM Code
042	B20	Acquired Immunodeficiency Syndrome (AIDS) Note: Medical coders are instructed to add codes for AIDS-associated malignancies. Screen 042 for history of cancers that might not be coded
079.4 79.5_	B97.7	Human papillomavirus; Retrovirus (HTLV, types I, II and 2)
173.01 173.02	C44.01 C44.02	Basal and squamous cell carcinoma of skin of lip
173.11 173.12	C44.111 C44.121	Basal and squamous cell carcinoma of eyelid, including canthus
173.2 173.22	C44.211 C44.221	Basal and squamous cell carcinoma of ear and external auricular canal
173.31 173.32	C44.31_ C44.32_	Basal and squamous cell carcinoma of skin of other and unspecified parts of face
173.41 173.42	C44.41 C44.42	Basal and squamous cell carcinoma of scalp and skin of neck
173.51 173.52	C44.51_ C44.52_	Basal and squamous cell carcinoma of skin of trunk, except scrotum
173.61 173.62	C44.611 C44.621	Basal and squamous cell carcinoma of skin of upper limb, including shoulder
173.71 173.72	C44.711 C44.721	Basal and squamous cell carcinoma of skin of lower limb, including hip
173.81 173.82	C44.81 C44.82	Basal and squamous cell carcinoma of other specified sites of skin
173.91 173.92	C44.91 C44.92	Basal and squamous cell carcinoma of skin, site unspecified
209.40 – 209.69	D3A._	Benign carcinoid tumors
210.0 – 229.9	D10._ – D31._ D34 D35.0 D35.1 D35.5 – D35.9 D36._	Benign neoplasms (except for 225.0-225.9, 227.3, 227.4, 228.02, 228.1, which are listed in the Reportable list) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
235.0 – 236.99	D37 ._ – D41._	Neoplasms of uncertain behavior Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
237.2 – 237.4	D44.1 D44.2 D44.6 – D44.9	Neoplasm of uncertain behavior of adrenal gland, paraganglia and other and unspecified endocrine glands Note: screen for incorrectly coded malignancies or reportable by agreement tumors
237.7_	Q85._	Neurofibromatosis and Schwannomastosis
238.0 – 239.9	D48._ D49._	Neoplasms of uncertain behavior (except for 238.4, 238. 6, 238. 7_, 239.6, 239.7, which are listed in the reportable list) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
249.20	E08._	Secondary diabetes mellitus with hypersmolarity Note: Includes diabetes in neoplastic disease
273.0	D89.0	Polyclonal hypergammaglobulinemia Note: screen for blood disorders due to neoplasm
273.1	D47.2	Monoclonal gammopathy of undetermined significance (9765/1) Note: Screen for incorrectly coded Waldenstrom macroglobulinemia or progression
273.2	D89.1	Other paraproteinemias
273.8 273.9	E88.09	Other and unspecified disorders of plasma protein metabolism Note: includes plasma disorders due to neoplastic disease
277.88	E88.3	Tumor lysis syndrome (following neoplastic chemotherapy)
279.02 279.03 279.05 279.12	D80.3 D80.4 D80.5	Select IgM immunodeficiency and other immunoglobulin deficiencies Note: Associated with lymphoproliferative disorders
279.2 279.3	D81.0 – D81.2 D81.6 D81.7 D81.89 D81.9 D84.9	Combined and unspecified immunity deficiency Note: Associated with lymphoproliferative disorders
279.41 279.49	D89.82 D89.89	Autoimmune lymphoproliferative syndrome Note: Associated with lymphoproliferative disorders
279.50 – 279.53	D89.81_	Graft-versus-host disease
279.8 279.9	D84.1 D89.82 D89.9	Other and unspecified disorders involving the immune mechanism Note: Associated with lymphoproliferative disorders
284.1_	D61.8_	Pancytopenia Note: screen for anemia disorder related to neoplasm
284.81	D60._	Red cell aplasia (acquired) (adult) (with thymoma) Note: screen for anemia disorder related to neoplasm
284.89	D61.1 – D61. D61.89 D61.9	Other specified aplastic anemias Note: screen for anemia disorder related to neoplasm
284.9	D61.9	Aplastic anemia Note: screen for anemia disorder related to neoplasm
285.0	D64.01 – D64.4	Sideroblastic anemia Note: screen for anemia disorder related to neoplasm
285.3	D64.81	Anemia due to antineoplastic chemotherapy
287.39 287.49 287.5	D69.49 D69.5 D69.6	Secondary, other primary and unspecified thrombocytopenia Note: Screen for incorrectly coded thrombocythemia
288.03	D70.1	Drug induced neutropenia Note: screen for anemia disorder related to neoplasm
288.3	D72.1	Eosinophilia Note: This is the code for eosinophilia (9964/3). Not every case of eosinophilia is associated with a malignancy. Diagnosis must be “Hypereosonophilic syndrome” to be reportable
289.89 289.9	D75.89 D75.9 D89.2	Other and unspecified diseases of blood and blood forming organs Note: screen for anemia disorder related to neoplasm
323.81	G04.81	Other causes of encephalitis and encephalomyelitis Note: includes encephalitis due to neoplasm
337.9	G90.9	Unspecified disorders of autonomic nervous system Note: Includes myelopathy in neoplastic diseases
338.3	G89.3	Neoplasm related pain (acute)(chronic)
352.9	G52.9	Unspecified disorder of cranial nerves Note: includes cranial nerves disorder in neoplastic disease
353.8	G54.8	Other nerve root and plexus disorders Note: includes nerve root and plexus disorders in neoplastic disease
516.5	J84.82	Adult pulmonary Langerhans cell histiocytosis
630	O01._	Hydatidiform mole Note: This is a benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) and will have a malignancy code in the 140-209 range
648.9_	O9A.1_	Other current conditions classifiable elsewhere complicating pregnancy Note: Includes: malignant neoplasm complicating pregnancy
713.8	M36.1	Arthropathy associated with other conditions Note: includes arthropathy in neoplastic disease
728.9	M62.9	Unspecified disorder of muscle, ligament, and fascia Note: Includes disorder of muscle, ligament, fascia in neoplastic disease
733.1_	M84.5_	Pathologic fracture Note: includes pathologic fracture due to neoplasm
758.0	Q90.0_	Down's Syndrome Note: Screen for leukemia associated with Down’s Syndrome (9898/3)
780.79	R53.0	Neoplastic (malignant) related fatigue
785.6	R59._	Enlargement of lymph nodes Note: Screen for large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease (9738)
790.93	R97.2	Elevated prostate specific antigen (PSA)
791.9	R82.8	Other non specific findings on examination of urine(abnormal findings on cytological and histological examination of urine)
792.0 792.2 792.4 792.9	R83.9 R84.9 R85.9 R86.9	Non specific abnormal findings in other body structures: cerebrospinal fluid, semen and saliva and other
793.11	R91.1	Solitary pulmonary nodule (Effective 10/1/2011)
793.8_	R92._	Nonspecific (abnormal) findings on radiological and examination of body structure (breast)
795.0_ – 795.1_	R87.6_	Papanicolaou smear of cervix and vagina with cytologic evidence of malignancy
795.4	R89.7	Other nonspecific abnormal histological findings
796.7_	R85.6_	Abnormal cytologic smear of anus and anal HPV
795.8_	R97._	Abnormal tumor markers; Elevated tumor associated antigens [TAA]
962.1	T38.6_	Poisoning by hormones and synthetic substitutes: Androgens and anabolic congeners
963.1	T45.1_	Poisoning by primarily systemic agents: antineoplastic and immunosuppressive drugs
990	T66	Effects of radiation, unspecified (radiation sickness)
996.54	T85.4_	Mechanical complication of other specified prosthetic device, implant, and graft-due to breast prosthesis
996.85	T86.0_	Complication of transplanted organ
999.3_	T80.2_	Complications due to central venous catheter
E858.0	T38.6_	Accidental poisoning by other drugs: Hormones and synthetic substitutes
E858.1	T45.1_	Accidental poisoning by other drugs: Primary systemic agents
E858.2	T45.8_ T45.9_	Agents primarily affecting blood constituents
E873.2	Y63.2	Failure in dosage, overdose of radiation in therapy (radiation sickness)
E878.0	Y83.0	Abnormal reaction of surgical operation with transplant of whole organ
E879.2	Y84.2	Overdose of radiation given during therapy (radiation sickness)
E930.7	None	Adverse reaction of antineoplastic therapy-Antineoplastic antibiotics
E932.1	None	Adverse reaction to antineoplastic therapy-Androgens and anabolic congeners
E933.1	None	Adverse effect (poisoning) of immunosuppressive drugs
V10.0_ – V10.9_	Z85.0_ – Z85.8_	Personal history of malignancy Note: Screen for recurrences, subsequent primaries, and/or subsequent treatment
V12.41	Z86.011	Personal history of benign neoplasm of the brain
V13.89	Z86.000 Z86.008 Z86.011	Personal history of unspecified malignant neoplasm and history of in-situ neoplasm of other site
V15.22	Z98.871	Personal history of undergoing in utero procedure during pregnancy Note: includes procedures on fetus for cancer related diagnosis
V15.3	Z92.3	Other personal history presenting hazards to health or radiation Note: Personal history of therapeutic radiation
V16._	Z80._	Family history of malignant neoplasm
V42.81 V42.82	Z94.81 Z94.84	Organ or tissue replaced by transplant bone marrow, stem cell
V51.0	Z42.1	Encounter for breast reconstruction following mastectomy
V52.4	Z44.3_	Fitting and adjustment of prosthetic device and implant (breast)
V54.2_	M84.5_	Aftercare for healing pathologic fracture
V58.0 V58.1_	Z51.0 Z51.1_	Encounter for radiotherapy, chemotherapy, immunotherapy
V58.42	M84.4_	Aftercare following surgery for neoplasm
V66.1 V66.2	Z51.89	Convalescence and palliative care following radiotherapy, chemotherapy
V66.7	Z51.5	Encounter for palliative care
V67.1 V67.2	Z08	Follow up examination: following radiotherapy or chemotherapy
V71.1	Z03.89	Observation for suspected malignant neoplasm
V72.83	Z01.818	Other specified pre-operative examination (including chemotherapy)
V76._	Z12._	Special screening for malignant neoplasms
V78.8 V78.9	Z13.0	Other and unspecified disorders of blood and blood forming organs
V86 ._	Z17 ._	Estrogen receptor positive status [ER+], negative status [ER-]
V87.41	Z92.21	Personal history of antineoplastic chemotherapy
V87.43	Z92.23	Personal history of estrogen therapy
V87.46	Z92.25	Personal history of immunosuppression therapy

The following codes are associated with the paraneoplastic syndrome. Paraneoplastic syndrome by itself is not cancer. It’s a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer. These codes have been removed from the supplemental list and are now in their own list.

ICD-9-CM Code*	ICD-10-CM Code**	Explanation of ICD-9-CM Code
253.6	E22.2	Syndrome of inappropriate secretion of antidiuretic hormone
259.2	E34.0	Carcinoid syndrome
259.8	E34.8	Other specified endocrine disorders
275.42	E83.52	Hypercalcemia
379.5_	H55._	Nystagmus and other irregular eye movements
686.01	L88	Pyoderma gangrenosum
694.4	L10.81	Pemphigus
695.89	L30.4 L53.8 L98.2	Other specified erythematous conditions
701.2	L83	Acquired acanthosis nigricans
710.3	M36.0	Dermatomyositis
710.4	M33.2_	Polymyositis

*International Classification of Diseases, 9th Revision, Clinical Modification, Sixth Edition (Hospital Edition), 2012

**International Classification of Diseases, ICD-10-CM Tabular List of Diseases and Injuries, 2012, DRAFT. All information regarding ICD-10-CM, including the conversions of ICD-9-CM to ICD-10-CM based on the 2012 General Equivalency Mappings provided by CMS and NCHS on the CDC website for ICD coding: http://www.cdc.gov/nchs/icd/icd10cm.htm